Tredence acquires KMK Consulting to expand pharma AI business, target $1 billion revenue by 2030
Published on: June 22, 2026, 7:49 p.m. | Source: Moneycontrol
The company expects healthcare and life sciences to emerge as a major growth engine, contributing about 25% of overall revenue by 2028 and generating around $100 million in annual revenue.
